Template:Available forms of progesterone

v
t
e
Available forms of progesterone^{[sources 1]}^[a]
Route	Form	Dose	Brand name	Availability^[b]
Oral	Capsule	100, 200, 300 mg	Prometrium^[c]	Widespread
Oral	Tablet (SR)	200, 300, 400 mg	Dubagest SR^[c]	India
Sublingual	Tablet	10, 25, 50, 100 mg	Luteina^[c]	Europe^[d]
Transdermal	Gel^[e]	1% (25 mg)	Progestogel	Europe
Vaginal	Capsule	100, 200, 300 mg	Utrogestan	Widespread
	Tablet	100 mg	Endometrin^[c]	Widespread
	Gel	4, 8% (45, 90 mg)	Crinone^[c]	Widespread
	Suppository	200, 400 mg	Cyclogest	Europe
	Ring	10 mg/day^[f]	Fertiring^[c]	South America^[g]
Rectal	Suppository	200, 400 mg	Cyclogest	Europe
Uterine	IUD	38 mg	Progestasert	Discontinued
Intramuscular injection	Oil solution	2, 5, 10, 20, 25, 50, 100 mg/mL	Proluton^[c]	Widespread
Aq. susp.	12.5, 30, 100 mg/mL	Agolutin^[c]	Europe^[h]
Emulsion	5, 10, 25 mg/mL	Di-Pro-Emulsion	Discontinued
Microsph.	20, 100 mg/mL	ProSphere^[c]	Mexico
Subcutaneous	Aq. soln. (inj.)	25 mg/vial	Prolutex	Europe
Subcutaneous	Implant	50, 100 mg	Proluton^[c]	Discontinued
Intravenous	Aq. soln. (inj.)	20 mg/mL	Primolut	Discontinued
Sources and footnotes: ↑ Sources: ^[1]^[2]^[3]^[4]^[5]^[6]^[7]^[8]^[9]^[10]^[11] ↑ This table only includes products where progesterone is the sole active ingredient. ↑ See also: Progesterone (medication) § Availability 1 2 3 4 5 6 7 8 9 10 Other brand names exist. ↑ Specifically in Poland and Ukraine. ↑ For local application to the breasts; negligible systemic effect. ↑ One progesterone vaginal ring provides 10mg of progesterone each day for 3 months. ↑ Specifically in Chile, Ecuador, and Peru. ↑ Specifically the Czech Republic and Slovakia.

[12] Sources: ^[1]^[2]^[3]^[4]^[5]^[6]^[7]^[8]^[9]^[10]^[11]

[13] This table only includes products where progesterone is the sole active ingredient.

[14] See also: Progesterone (medication) § Availability

[others-15] 1 2 3 4 5 6 7 8 9 10 Other brand names exist.

[16] Specifically in Poland and Ukraine.

[17] For local application to the breasts; negligible systemic effect.

[18] One progesterone vaginal ring provides 10mg of progesterone each day for 3 months.

[19] Specifically in Chile, Ecuador, and Peru.

[20] Specifically the Czech Republic and Slovakia.

[Drugs@FDA-1] "Drugs@FDA: FDA Approved Drug Products". United States Food and Drug Administration. Retrieved 26 July 2018.

[EngelKleemann2014-2] Engel J, Kleemann A, Kutscher B, Reichert D (14 May 2014). Pharmaceutical Substances, 5th Edition, 2009: Syntheses, Patents and Applications of the most relevant APIs. Thieme. pp. 1145–. ISBN 978-3-13-179275-4.

[Becker2001-3] Becker KL (2001). Principles and Practice of Endocrinology and Metabolism. Lippincott Williams & Wilkins. pp. 2168–. ISBN 978-0-7817-1750-2.

[MVJain2018-4] Anita MV, Jain S, Goel N (31 July 2018). Use of Progestogens in Clinical Practice of Obstetrics and Gynecology. JP Medical Ltd. pp. 4–. ISBN 978-93-5270-218-3.

[Sauer2013-5] Sauer MV (1 March 2013). Principles of Oocyte and Embryo Donation. Springer Science & Business Media. pp. 7, 117–118. ISBN 978-1-4471-2392-7.

[ElderDale2010-6] Elder K, Dale B (2 December 2010). In-Vitro Fertilization. Cambridge University Press. pp. 26–. ISBN 978-1-139-49285-0.

[P.R.-Vademecum-ProSphere-7] "PROSPHERE CARNOT". Archived from the original on 2019-12-30.

[Kahr2013-8] Heinrich Kahr (8 March 2013). Konservative Therapie der Frauenkrankheiten: Anzeigen, Grenzen und Methoden Einschliesslich der Rezeptur. Springer-Verlag. pp. 21–. ISBN 978-3-7091-5694-0.

[Schering1962-9] Basic Sex Hormone Therapy. Schering A.G. 1962. p. 96.

[CurrMedDrugs1962-10] Current Medicine and Drugs. 1962. p. 40. Primolut Intravenous (Schering A.G. Berlin)

[HaleemKhan2015-11] Haleem S, Khan MI (March 2015). "Changing Indian Market Trends of NMP: A Review" (PDF). International Journal of Pharma Research & Review. 4 (3): 28–30. ISSN 2278-6074. S2CID 74224514.

[sources 1]

[a]

[b]

[c]

[d]

[e]

[f]

[g]

[h]

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]

Template:Available forms of progesterone

See also

References